Johnson & Johnson will showcase its electrophysiology portfolio at the 2026 Heart Rhythm Society (HRS) Annual Meeting. The company will launch the CARTOSOUND SONATA Module. This module uses artificial intelligence to create 3D cardiac maps from ultrasound images.
J&J will present clinical and real-world data on its VARIPULSE Platform for atrial fibrillation. These technologies integrate into the CARTO System for heart rhythm disorders.
The updates highlight J&J MedTech’s focus on AI and technology to improve arrhythmia care.